Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer


Condition: Prostate Cancer, Radiation Toxicity

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT00769223

Sponsor: University of California, San Francisco

Phase:

Eligibility:

  • Age: minimum 18 Years maximum 120 Years
  • Gender: Male

Disease Characteristics:

  • Diagnosis of localized adenocarcinoma of the prostate
  • Has undergone radiotherapy (external beam radiotherapy and/or brachytherapy) with or without hormonal therapy for adenocarcinoma of the prostate in the University of California, San Francisco (UCSF) Radiation Oncology Department at San Francisco General Hospital or Veterans Administration Medical Center of San Francisco between 1987 and 2006

Patient Characteristics:

  • Not specified

Prior Concurrent Therapy:

  • See Disease Characteristics

View trial on ClinicalTrials.gov